Searched for
PROAIR
Pharma stock that Jhunjhunwala exited in Q2 is now buzzing. Here's what analysts sayAce investor Rakesh Jhunjhunwala probably exited this counter in the second quarter, as his name was not among the shareholders holding ove...15 Dec, 2021, 12.23 PM IST- Apple event 2021: Mini-LED iPad Pro, AirTags may drop at 'Spring Loaded'. Here's what to expect & where to watch itThe tech company may also unveil the new Airpods, Apple Pencil & redesigned iMac.20 Apr, 2021, 09.39 PM IST
- Add Lupin, target price Rs 1060: Centrum BrokingLupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 40764.44 Crore) operating in Pharmaceuticals s...13 Nov, 2020, 11.57 AM IST
- Cipla, Lupin may gain from Perrigo's drug recall, says MacquariePerrigo announced the voluntary nationwide recall of albuterol sulfate following complaints that some units may not dispense due to cloggin...18 Sep, 2020, 03.22 PM IST
- Licence to sell cancer drug biggest opportunity for Dr Reddy’s in US market: Nirmal Bang‘On a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.’18 Sep, 2020, 11.44 AM IST
- Pharma’s perennial underperformer gets a shot in the arm. Can it deliver?The stock has gained 64 per cent from March lows and 27 per cent year to date, but still 54 per cent down from its all-time high of Rs 2,12...26 Aug, 2020, 05.07 PM IST
- Expect good gross margins from ProAir generic due to price stickiness: Lupin CFOIt is a product which has a very high level of complexity and there is a fair degree of stickiness associated with it because we do not exp...26 Aug, 2020, 02.37 PM IST
- Lupin gets US health regulator's approval for asthmatic symptoms prevention drugThe approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc. In a regulatory filing, Lupin sai...25 Aug, 2020, 10.45 AM IST
- Buy Cipla, target price Rs 668: ICICI SecuritiesThe brokerage has raised FY21-FY22 EPS estimates by 11-12 per cent on generic Proventil approval and the increase in Rs/$ rate to 74 from 7...13 Apr, 2020, 12.08 PM IST
- Buy Cipla, target price Rs 522: Emkay GlobalCipla has received approval for generic proventil MDI (Albuterol Sulphate 90mcg/inhalation). This can lead to 3-4 per cent EPS accretion to...13 Apr, 2020, 09.55 AM IST
- Equirus retains reduce on Lupin, target price Rs 684Reduce Lupin Ltd. at a price target of Rs 684.0 .18 Oct, 2019, 08.15 AM IST
- Analyst Calls: Bajaj Auto, Mindtree, Lupin, DB CorpJefferies has an underperform rating on Bajaj Auto with a target price of Rs 2,650.18 Oct, 2019, 07.29 AM IST
- Sell Lupin, target Rs 800: Elara CapitalSell Lupin at a price target of Rs 800.25 Apr, 2019, 05.25 PM IST
- Reduce Lupin, target Rs 840: Kotak Institutional EquitiesReduce Lupin at a price target of Rs 840.24 Apr, 2019, 01.52 PM IST
- Buy Lupin, target Rs 985: HDFC SecuritiesBuy Lupin at a price target of Rs 985.11 Feb, 2019, 12.33 PM IST
- Lupin still on track to meet $800-million FY19 sales target: Ramesh SwaminathanThings not as bad as they were in the past and should be looking better, says Lupin CFO.01 Nov, 2018, 04.04 PM IST
- Brokerages raise Cipla's target price post inhaler launchAnalysts at Emkay Global Financial Services are of the view that the launch will have a strong positive impact on the company’s margins.02 Sep, 2014, 11.44 AM IST
Load More
